Small Business Resources, Business Advice and Forms from AllBusiness.com

The Medicines Company to Present at Pacific Growth Equities and Needham & Company.

PARSIPPANY, N.J. -- The Medicines Company (NASDAQ: MDCO) is scheduled to present at the Pacific Growth Equities Life Sciences Growth Conference 2006 on Wednesday, June 14th, at 7:30 am Pacific Time in San Francisco and at the Needham Biotech Conference at 2:30 pm Eastern Time in New York City.

In both presentations, a company overview and outlook will be provided.

Both sessions will be webcast with links available at The Medicines Company's website: http://www.themedicinescompany.com.

About The Medicines Company

The Medicines Company meets the demands of the world's most advanced medical practitioners by developing products that improve acute hospital care. The Company markets Angiomax(R) (bivalirudin), an anti-clotting therapy approved in the U.S. and other countries for use in patients undergoing coronary angioplasty, a procedure to clear restricted blood flow in arteries around the heart. The Medicines Company creates value using its range of clinical and commercial skills to develop products acquired from leading life science innovators.

In addition, make sure to read these articles: